"To be truly effective, measures to contain MRSA must block airborne transmission"     N. A. Simmons

Emeritus Consultant Microbiologist at the Guy's and St. Thomas' Hospital Trust.
Letter to The Times - March 2005

Breakthrough Technology Prevents
Spread of Airborne Infection

Press Release - 17th January 2007

The ever-present threat of healthcare acquired infection has brought misery and bereavement to countless families throughout the UK. The NHS has responded with an on-going infection prevention programme in our hospitals at a cost to date in excess of £1 billion. Despite this, the Health Protection Agency has warned that infection rates of MRSA and more recently C.difficile continue to rise at an alarming rate. Cases of C.difficile among the over 65's have increased by more than 17%.

The emphasis to date in hospitals has been on cleaning, hand washing and barrier nursing. Although infection awareness is now high in our hospitals these procedures are only having a limited effect on infection rates. The major problem, yet to be overcome, is the threat of airborne infection. MRSA is spread from nose, mouth and skin particles, shed by carriers, drifting in the air. Until now there has been no effective process of combating the transmission of airborne infection.

This breakthrough could radically improve the way we combat infection in our hospitals and complements the effective Viroklenz dual biocide rotation cleansing system. The Viroklenz Medairsan technology allows activation of powerful biocides within the airflow of the machine. The smaller machine has been designed for use at the patients' bedside and a larger wall mounted unit for use in communal areas. Each of these units contains a biodegradable 'refill' impregnated with a biocide formulation that is unique to Viroklenz. The biocides are proven to kill known pathogens, including MRSA, Avian Influenza H5N1, C.difficile and many others.

Please click here to download the full PDF version to continue reading this press release.
 

Featured Article - Yorkshire Post Today - 17th January 2007

Harrogate-based Viroklenz Infection Protection says the equipment contains a biocide formulation which kills known pathogens, including the superbug MRSA, the H5N1 strain of bird flu and C.difficile, a bacteria which attacks the intestine and can be fatal.

Click here to visit the Yorkshire Post Today and read the full article.
 

Featured Article - Harrogate Today - 19th January 2007

A ground-breaking new machine could help fight the battle against superbug MRSA and bird flu.
A company claims it has developed the first contraption able to combat the threat to hospital patients of airbourne infections.

Click here to visit the Harrogate Today and read the full article.